Skip to main content
BMJ Open logoLink to BMJ Open
. 2024 Feb 13;14(2):e077015. doi: 10.1136/bmjopen-2023-077015

Depression and associated factors among HIV-positive smokers receiving care at HIV outpatient clinics in Vietnam: a cross-sectional analysis

Nam Truong Nguyen 1,, Trang Nguyen 1, Giap Van Vu 2, Nga Truong 1, Yen Pham 1, Gloria Guevara Alvarez 3, Mari Armstrong-Hough 3, Donna Shelley 3
PMCID: PMC10868293  PMID: 38355191

Abstract

Objectives

To assess the prevalence of depressive symptoms and associated factors among people living with HIV (PLWH) who were current cigarette smokers and receiving treatment at HIV outpatient clinics (OPCs) in Vietnam.

Design

A cross-sectional survey of smokers living with HIV.

Setting

The study was carried out in 13 HIV OPCs located in Ha Noi, Vietnam.

Participants

The study included 527 PLWH aged 18 and above who were smokers and were receiving treatment at HIV OPCs.

Outcome measures

The study used the Centre for Epidemiology Scale for Depression to assess depressive symptoms. The associations between depressive symptoms, tobacco dependence and other characteristics were explored using bivariate and Poisson regression analyses.

Results

The prevalence of depressive symptoms among smokers living with HIV was 38.3%. HIV-positive smokers who were female (prevalence ratio, PR 1.51, 95% CI 1.02 to 2.22), unmarried (PR 2.06, 95% CI 1.54 to 2.76), had a higher level of tobacco dependence (PR 1.06, 95% CI 1.01 to 1.11) and reported their health as fair or poor (PR 1.66, 95% CI 1.22 to 2.26) were more likely to have depression symptoms compared with HIV-positive smokers who were male, married, had a lower level of tobacco dependence and self-reported their health as good, very good or excellent.

Conclusion

The prevalence of depressive symptoms among smokers receiving HIV care at HIV OPCs was high. Both depression and tobacco use screening and treatment should be included as part of ongoing care treatment plans at HIV OPCs.

Keywords: Depression & mood disorders, HIV & AIDS, MENTAL HEALTH, PUBLIC HEALTH


STRENGTHS AND LIMITATIONS OF THIS STUDY.

  • The study used the Centre for Epidemiology Scale for Depression (CES-D 8), a validated scale to screen depressive symptoms and was conducted with a large sample of smokers living with HIV and receiving treatment at HIV outpatient clinics.

  • Using the CES-D 8, which is a screening tool rather than a diagnostic instrument, this study could only assess the prevalence of depressive symptoms among people living with HIV (PLWH) instead of the prevalence of diagnosed depression.

  • The study employed Poisson regression to estimate prevalence ratios, a more robust approach than logistic regression for analysing cross-sectional studies with binary outcomes.

  • The cross-sectional design did not allow for conclusions about the direction of the associations between depression and other factors.

  • The study sample, which included PLWH who were receiving treatment at HIV outpatient clinics, may not represent the larger population of PLWH in Vietnam.

Introduction

HIV infection remains a significant public health issue, with over 38 million people living with HIV (PLWH) globally.1 With increased access to antiretroviral medication, HIV infection has become a manageable chronic health condition with a lifespan comparable to that of the general population.2 3 However, the growing burden of non-communicable diseases threatens gains in life expectancy among PLWH.4 This is in part due to high rates of tobacco use in this population, particularly in LMIC countries such as Vietnam, where smoking prevalence among male PLWH is over 50%.4 5 PLWH who use tobacco are at an increased risk of HIV and non-HIV-related chronic diseases that include cancer and cardiovascular diseases compared with PLWH who do not smoke.6

PLWH experience other risk factors for poor health that include higher rates of depression compared with the general population.7–9 Prevalence estimates for depression among PLWH range widely from 25.6% to 56.7%.6 10–15 Studies conducted in Vietnam show a similarly high prevalence of depression among PLWH, ranging from 18.7% to 44%.16–21

Depression is common among smokers, particularly among smokers living with HIV.22 23 The high co-occurrence of smoking and depression in this population is a significant public health concern. Depression may contribute to lower smoking cessation rates, negatively impacts adherence to to antiretroviral therapy (ART) and is associated with faster progression of the disease and a higher prevalence of other health risk behaviours, including alcohol abuse and drug use and poorer health outcomes.22 24–29

Despite the deleterious effects of the co-occurrence of depression and tobacco use on health outcomes among PLWH, there is a lack of data on the correlates of depression in this population. To begin to fill this gap in research, we conducted a cross-sectional analysis of factors associated with depressive symptoms among PLWH who smoked and were receiving treatment in HIV outpatient clinics (OPCs) in Ha Noi, Vietnam.

Methods

Study design

We analysed data from baseline surveys conducted with 527 patients living with HIV who were enrolled in a randomised controlled trial that compared the effectiveness of three smoking cessation interventions among PLWH who received care from 13 HIV OPCs in Ha Noi, Vietnam. The surveys were conducted between December 2022 and June 2023. Participants were screened for tobacco use at the time of registration for a routine visit. Participants were eligible to enrol if they were 18 or older, active patients at the OPCs, current cigarette-only or dual users (water pipes and cigarettes), had a mobile phone and lived in Ha Noi. Our analysis revealed no significant differences in gender, age and smoking status between patients who declined to participate and those who enrolled in the study.

The survey was administered in person using a structured questionnaire in Vietnamese.

Measures

Dependent variable

The study used the eight-item Centre for Epidemiology Scale for Depression (CES-D 8) to assess depressive symptoms.30 The CES-D 8 was previously validated in Vietnam.31 In this study, Cronbach’s alpha was 0.76, demonstrating a high level of internal consistency of the CES-D 8.

The survey asked respondents how often they experienced certain feelings in the past week. These include feeling depressed, feeling that everything they did was an effort, having restless sleep, feeling happy, feeling lonely, enjoying life, feeling sad and having difficulty getting going. Responses were coded as 0=rarely or none of the time (less than 1 day); 1=some or a little of the time (1–2 days); 2=occasionally or a moderate amount of time (3–4 days) and 3=most or all of the time (5–7 days). Scores can range from 0 to 24. A score of ≥9 indicates the presence of depressive symptoms.32

Independent variables

Health status was measured using a single question: ‘Would you say your health in general is excellent, very good, good, fair or poor?’ where 1=poor, 2=fair, 3=good, 4=very good and 5=excellent.33

Social support was assessed using the Multidimensional Scale of Perceived Social Support Scale,34 which aggregates three types of social support: significant other, family and friends. Respondents were asked to rate 12 social support statements on a scale of 1–4, where 1 indicated ‘strongly disagree’ and 4 indicated ‘strongly agree’. The mean scores for each of the three social support categories were calculated.

Tobacco dependence was assessed using the Fagerstrom Test for Nicotine Dependence, which consists of six items that evaluate the quantity of cigarette consumption, the compulsion to use and dependence.35 The measured levels of tobacco dependence ranged from ‘very low dependence’ with a score of 0–2 to ‘very high dependence’ with a score of 8–10.

Alcohol use was assessed using the Alcohol Use Disorder Identification Test-Consumption (AUDIT-C).36 The AUDIT-C scale ranges from 0 to 12. Hazardous drinking was defined as a score of ≥4 for men and ≥3 for women.37

Drug use was defined as the use of substances for psychotropic rather than medical purposes. The assessment of drug use was based on two questions that asked if respondents had ever used, and if they used in the past 3 months, any of the following substances: opium, cocaine, heroin, amphetamine/methamphetamine, marijuana, ecstasy, MDMA and ketamine.

HIV characteristics include the number of years a person has lived with HIV and the duration of ART use. Having a chronic disease was assessed using one question that asked if the respondent has ever been diagnosed with any of the following chronic diseases: high blood pressure, diabetes, cancer and lung disease. Sociodemographic variables include sex, age, marital status, educational status, household income, occupation and living arrangements (eg, living with children).

Data analysis

The data were analysed by using Stata (V.14.0). Descriptive statistics were used to summarise the characteristics of PLWH and the prevalence of depressive symptoms. Bivariate tests were conducted with a significance level of 0.05. Categorical variables were assessed via χ2 tests, while continuous variables were assessed using t-tests. Multivariable analysis was performed using Poison regression38 to evaluate the associations between depression and other patient characteristics. Prevalence ratios (PRs) were reported along with 95% CIs. Independent variables that had a p<0.2 in the bivariate analyses were included in the logistic regression model.39 P values<0.05 were considered statistically significant.

Patient and public involvement

No patients or members of the public were involved in the design, conduct, reporting and dissemination of the study.

Results

Sociodemographic characteristics of the participants

A total of 527 PLWH were included in the study, of which 95.8% were male and 4.2% were female. This low prevalence of female smokers was consistent with national data demonstrating that less than 2% of women in Vietnam smoke cigarettes.40 The average age of PLWH was 44.3 (±7.0). In terms of marital status and living arrangements, 53.9% of participants were married, while 46.1% were single, separated, divorced or widowed, and 70.6% lived with spouses, partners and children. Regarding education, employment and income, 45.7% of participants had not completed high school education, 63.4% worked in small businesses, trading, services or freelance, and 59.6% had an annual household income from VND100 to VND300 million (table 1).

Table 1.

PLWH’s characteristics and bivariate analysis of factors associated with depressive symptoms

Characteristics Total Depressive symptoms P value
No Yes
n %
/mean±SD
n %
/mean±SD
n %
/mean±SD
Gender
 Female 22 4.2 9 40.9 13 59.1 0.041
 Male 505 95.8 316 62.6 189 37.4
Age (mean) 527 44.3±7.0 325 44.6±7.0 202 43.8±6.9 0.174
Marital status
 Single/never married/separated/divorced 243 46.1 107 44.0 136 56.0 <0.001
 Married 284 53.9 218 76.8 66 23.2
Education
 Less than high school 241 45.7 151 62.7 90 37.3 0.473
 High school 193 36.6 113 58.6 80 41.4
 Vocational training/college/university and above 93 17.7 61 65.6 32 34.4
Occupation
 Private sector 108 20.5 71 65.7 37 34.3 0.038
 Small business/trading/services/freelance 334 63.4 193 57.8 141 42.2
 Others 85 16.1 61 71.8 24 28.2
Household income in the past 12 months
 VND50 000 000 to <VND100 000 000 153 29.0 88 57.5 65 42.5 0.425
 VND100 000 000 to <VND300 000 000 314 59.6 200 63.7 114 36.3
 VND300 000 000 to over VND500 000 000 57 10.8 36 63.2 21 36.8
Living arrangements
 Live alone 44 8.3 20 45.5 24 54.5 <0.001
 Live with spouse/partner/children/grandchildren 372 70.6 257 69.1 115 30.9
 Live with others 111 21.1 48 43.2 63 56.8
Duration of diagnosed with HIV 527 12.5±6.4 325 12.4±6.5 202 12.8±6.3 0.449
Duration of antiretroviral therapy 527 10.1±6.5 325 10.0±5.5 202 10.3±7.9 0.643
Have depressive symptoms
 No 325 61.7
 Yes 202 38.3
Have a chronic disease
 No 412 78.2 262 63.6 150 36.4 0.086
 Yes 115 21.8 63 54.8 52 45.2
Current health status
 Good/very good/excellent 149 28.3 113 75.8 36 24.2 <0.001
 Fair/poor 378 71.7 212 56.1 166 43.9
Type of smoker
 Cigarettes only 256 48.6 158 61.7 98 38.3 0.982
 Dual user 271 51.4 167 61.6 104 38.4
Tobacco dependence level
 Very low/low 248 47.1 174 70.2 74 29.8 0.001
 Medium 75 14.2 41 54.7 34 45.3
 High/very high 204 38.7 110 53.9 94 46.1
 Tobacco dependence (score) 527 4.4±2.5 325 4.0±2.6 202 5.0±2.3 <0.001
Hazardous drinking
 No 237 45.0 136 57.4 101 42.6 0.067
 Yes 290 55.0 189 65.2 101 34.8
Drug use
 Never 102 19.4 73 71.6 29 28.4 0.026
 Ever 327 62.1 200 61.2 127 38.8
 In the last 3 months 98 18.6 52 53.1 46 46.9
Social support
 Family support score 527 3.2±0.5 325 3.2±0.5 202 3.1±0.5 0.100
 Friend support score 527 2.9±0.6 325 2.9±0.5 202 2.8±0.5 0.211
 Other support score 527 3.2±0.5 325 3.2±0.5 202 3.1±0.5 0.041
Total social support score (min–max: 1.33–4.33) 527 3.3±0.4 325 3.4±0.4 202 3.3±0.4 0.038

PLWH, people living with HIV.

The mean duration of HIV diagnosis and ART treatment was 12.5 years (±6.4) and 10.1 years (±6.5).

In terms of health behaviour, 48.6% were cigarette-only smokers, while 51.4% were dual users, meaning they smoked both cigarettes and water pipes. Moreover, 38.7% had a high or very high level of tobacco dependence, 55% had hazardous drinking habits, 62% reported having ever used drugs and 18.6% had used drugs in the last 3 months.

Regarding health status, 71.7% reported very poor or poor health status, and 21.8% had at least one chronic disease.

Prevalence and associated factors of depressive symptoms

The prevalence of depressive symptoms, as measured by a CED-8 score of 9 or higher, was 38.3% (table 1).

Table 1 shows the results of bivariate analyses that examined the correlation between depressive symptoms and other patient characteristics. The prevalence of depressive symptoms was higher among PLWH who were female, unmarried, worked in small business, trading, services and freelance, lived alone, reported fair or poor health status, had higher tobacco dependence levels, used drugs in the past 3 months, and reported lower levels of social support. In comparison, those who were male, married, worked in the private sector or other, lived with a spouse, partner, children or with others, reported good, very good or excellent health status, had lower levels of tobacco dependence, never used drugs and had higher social support had a lower prevalence of depressive symptoms.

Table 2 presents results from multivariate analyses indicating significant associations between depressive symptoms and gender, marital status, level of tobacco dependence and self-reported health status.

Table 2.

Multivariate analysis of factors associated with depressive symptoms among PLWH using Poisson regression

Characteristics PR (95% CI) P value
Gender
 Male (ref.)
 Female 1.51 (1.02 to 2.22) 0.039
Age (mean) 1.00 (0.99 to 1.02) 0.914
Marital status
 Married (ref.)
 Single/never married/separated/divorced 2.06 (1.54 to 2.76) <0.001
Occupation
 Private sector (ref.)
 Small business/trading/services/freelance 1.08 (0.82 to 1.42) 0.583
 Others 0.75 (0.50 to 1.12) 0.166
Living arrangements
 Live alone (ref.)
 Live with spouse/partner/children/grandchildren 0.96 (0.68 to 1.35) 0.819
 Live with others 1.04 (0.75 to 1.44) 0.815
Have a chronic disease
 No (ref.)
 Yes 1.16 (0.94 to 1.45) 0.161
Current health status
 Good/very good/excellent (ref.)
 Fair/poor 1.66 (1.22 to 2.26) 0.001
Tobacco dependence (score) 1.06 (1.01 to 1.11) 0.014
Hazardous drinking
 No (ref.)
 Yes 0.86 (0.71 to 1.05) 0.150
Drug use
 Never (ref.)
 Ever 1.08 (0.78 to 1.49) 0.647
 In the last 3 months 1.08 (0.76 to 1.53) 0.686
Total social support score 0.91 (0.72 to 1.15) 0.411

Bold values signify significant findings at p<0.05.

PLWH, people living with HIV; PR, prevalence ratio.

The probability of having depressive symptoms was significantly higher among females (PR 1.51, 95% CI 1.02 to 2.22), unmarried patients (PR 2.06, 95% CI 1.54 to 2.76), patients with higher levels of tobacco dependence (PR 1.06, 95% CI 1.01 to 1.11) and those with fair or poor health status (PR 1.66, 95% CI 1.22 to 2.26), compared with patients who were males, married, had a lower level of tobacco dependence and reported good, very good or excellent health status.

Discussion

This study found a high prevalence of depressive symptoms (38.3%) among PLWH who smoked and were receiving HIV care in OPCs in Vietnam. This prevalence is 16 times higher than the previously reported prevalence of depressive symptoms in the general Vietnamese population (2.5%).41 Our findings are consistent with prior studies showing a high prevalence of depressive symptoms among PLWH compared with the general population.7 9

Depression is the most common mental health problem among PLWH.42 43 The high prevalence of depressive symptoms in this population is attributed to HIV-associated biological factors and psychosocial factors, which include occupational disability, financial difficulties, stigma, discrimination, isolation and debilitation.44–47

We found that smokers living with HIV with higher levels of tobacco dependence were more likely to report higher levels of depressive symptoms compared with smokers living with HIV who had a lower level of tobacco dependence. The literature on the direction of this relationship is inconsistent.48–50 PLWH with depression may use nicotine to elevate their mood. On the other hand, smoking may lead to depression through changes in the brain’s susceptibility to environmental stress.50 51 Concern among clinicians about exacerbating depression symptoms has hindered the treatment of tobacco use. However, there is a growing evidence that suggests that smoking cessation has beneficial effects on mental health symptoms.52 It is critically important to develop and implement models of care that combine mental health and tobacco cessation for this population.

The prevalence of depressive symptoms among female smokers living with HIV was higher than that among male smokers living with HIV. This finding is consistent with previous studies that depression is more common among women with HIV compared with the general population, women without HIV53 and men with HIV.54–56 Women are at a higher risk of depression due to a variety of factors, including genetic vulnerability, reproductive hormones, internalisation coping strategies, gender-specific roles and life stress.57 58 In addition, women living with HIV experience higher levels of perceived stress and HIV stigma.54 These added stressors may consequently contribute to an increased risk of depression among women with HIV.

Consistent with other studies on PLWH,8 59 this study found a higher prevalence of depressive symptoms among unmarried smokers living with HIV. Having a diagnosis of HIV, a disease that is associated with high levels of perceived stigma, may prevent PLWH from entering and maintaining a marital relationship. HIV-associated stigma may lead to social isolation and loneliness for those without meaningful relationships and social ties.60 Increased loneliness and isolation, along with a lack of psychological and tangible support, may increase the risk of depression among PLWH who are not married. Social support, particularly from significant others, can reduce perceived stigma and consequently decrease the risk of depression and is also associated with improved quality of life, reduced symptoms of depression and better adherence to ART.61 More research is needed to identify effective methods for enhancing social support in the context of HIV care.

Finally, this study is consistent with previous studies19 21 that found an association between self-reported poor health and depressive symptoms. The direction of this relationship is also not clear and may, in part, be related to concurrent tobacco use. However, the finding further highlights that optimising quality of life and health outcomes requires addressing both mental health and tobacco use as part of routine HIV care.

There are some limitations to this analysis. First, the cross-sectional design does not allow for conclusions about the direction of the associations. For example, poorer health may contribute to depressive symptoms and vice versa. Second, participants were drawn from a sample of PLWH who were receiving treatment at HIV OPCs. Therefore, this sample of PLWH may not represent the larger population of PLWH in Vietnam. However, most PLWH in Vietnam receive ART at OPCs. Lastly, the CES-D 8 is a screening tool rather than a diagnostic instrument. As a result, this study was only able to assess the prevalence of depressive symptoms among PLWH rather than the prevalence of diagnosed depression.

Conclusions

Findings from this study and prior literature indicate that there is a high prevalence of co-occurring depression and tobacco use among PLWH, which negatively impacts disease progression and health outcomes in this population. Thus, it is imperative to provide resources and training to integrate screening and effective treatment for both tobacco use and depression into routine care in HIV treatment settings. Further enhancing social support through additional services and programmes may facilitate engagement in tobacco use treatment and improve health outcomes among PLWH who smoke.51

Supplementary Material

Reviewer comments
Author's manuscript

Footnotes

Contributors: Designed the study: DS and NTN. Developed data collection tools: DS, NTN, TN, GGA, MA-H and GVV. Collected data: NT and YP. Analysed data and interpreted results: TN, NT and YP. Wrote the initial draft: NTN and DS. Contributed to subsequent drafts: DS, GGA, MA-H, TN and GVV. All authors reviewed and approved the final manuscript. NTN is responsible for the overall content as the guarantor.

Funding: This work was supported by the National Cancer Institute, US National Institutes of Health (grant number R01CA240481).

Competing interests: None declared.

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data availability statement

Data are available on reasonable request.

Ethics statements

Patient consent for publication

Not applicable.

Ethics approval

All participants provided written informed consent. The institutional review boards of the Institute of Social Medical Studies (Decision 08/HDDD-ISMS) and the New York University School of Medicine (ID i19-01783) approved this research.

References

  • 1.World Health Organization . Factsheet. HIV and AIDS. 2023. Available: https://www.who.int/news-room/fact-sheets/detail/hiv-aids
  • 2.Mdege ND, Shah S, Ayo-Yusuf OA, et al. Tobacco use among people living with HIV: analysis of data from demographic and Health Surveys from 28 low-income and middle-income countries. Lancet Glob Health 2017;5:e578–92. 10.1016/S2214-109X(17)30170-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 2011;155:209–16. 10.7326/0003-4819-155-4-201108160-00358 [DOI] [PubMed] [Google Scholar]
  • 4.Parascandola M, Neta G, Bloch M, et al. Colliding epidemics: research gaps and implementation science opportunities for tobacco use and HIV/AIDS in low- and middle-income countries. J Smok Cessat 2022;2022:6835146. 10.1155/2022/6835146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nguyen NPT, Tran BX, Hwang LY, et al. Prevalence of cigarette smoking and associated factors in a large sample of HIV-positive patients receiving antiretroviral therapy in Vietnam. PLoS One 2015;10:e0118185. 10.1371/journal.pone.0118185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Abadiga M. Depression and its associated factors among HIV/AIDS patients attending ART clinics at Gimbi General hospital, West Ethiopia, 2018. BMC Res Notes 2019;12:527. 10.1186/s13104-019-4553-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001;158:725–30. 10.1176/appi.ajp.158.5.725 [DOI] [PubMed] [Google Scholar]
  • 8.Mekonen T, Belete H, Fekadu W. Depressive symptoms among people with HIV/AIDS in Northwest Ethiopia: comparative study. BMJ Open 2021;11:e048931. 10.1136/bmjopen-2021-048931 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep 2008;5:163–71. 10.1007/s11904-008-0025-1 [DOI] [PubMed] [Google Scholar]
  • 10.Ayano G, Tsegay L, Solomon M. Food insecurity and the risk of depression in people living with HIV/AIDS: a systematic review and meta-analysis. AIDS Res Ther 2020;17:36. 10.1186/s12981-020-00291-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gritz ER, Vidrine DJ, Lazev AB, et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004;6:71–7. 10.1080/14622200310001656885 [DOI] [PubMed] [Google Scholar]
  • 12.Brown T, Morgan K. Psychological distress and substance abuse in Jamaican youths living with HIV/AIDS. West Indian Med J 2013;62:341–5. 10.7727/wimj.2013.024 [DOI] [PubMed] [Google Scholar]
  • 13.Zhang C, Li X, Liu Y, et al. Substance use and psychosocial status among people living with HIV/AIDS who encountered HIV stigma in China: stratified analyses by socio-economic status. PLOS ONE 2016;11:e0165624. 10.1371/journal.pone.0165624 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Duko B, Geja E, Zewude M, et al. Prevalence and associated factors of depression among patients with HIV/AIDS in Hawassa, Ethiopia, cross-sectional study. Ann Gen Psychiatry 2018;17:45. 10.1186/s12991-018-0215-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Olanrewaju GT IB. Prevalence and correlates of depressive disorders among people living with HIV/AIDS, in North Central Nigeria. J AIDS Clin Res 2013;04:01. 10.4172/2155-6113.1000251 [DOI] [Google Scholar]
  • 16.Esposito CA, Steel Z, Gioi TM, et al. The prevalence of depression among men living with HIV infection in Vietnam. Am J Public Health 2009;99 Suppl 2(Suppl 2):S439–44. 10.2105/AJPH.2008.155168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Matsumoto S, Yamaoka K, Takahashi K, et al. Social support as a key protective factor against depression in HIV-infected patients: report from large HIV clinics in Hanoi, Vietnam. Sci Rep 2017;7:15489. 10.1038/s41598-017-15768-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Huynh V-AN, To KG, Do DV, et al. Changes in depressive symptoms and correlates in HIV+ people at An Hoa Clinic in Ho Chi Minh City, Vietnam. BMC Psychiatry 2017;17:35. 10.1186/s12888-016-1170-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Thai TT, Jones MK, Harris LM, et al. Symptoms of depression in people living with HIV in Ho Chi Minh City, Vietnam: Prevalence and Associated Factors. AIDS Behav 2018;22(Suppl 1):76–84. 10.1007/s10461-017-1946-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Green K, Tuan T, Hoang TV, et al. Integrating palliative care into HIV outpatient clinical settings: preliminary findings from an intervention study in Vietnam. J Pain Symptom Manage 2010;40:31–4. 10.1016/j.jpainsymman.2010.04.006 [DOI] [PubMed] [Google Scholar]
  • 21.Levintow SN, Pence BW, Ha TV, et al. Prevalence and predictors of depressive symptoms among HIV-positive men who inject drugs in Vietnam. PLoS One 2018;13:e0191548. 10.1371/journal.pone.0191548 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Junaid K, Afzal S, Daood M, et al. Substance abuse and mental health issues among HIV/AIDS patients. J Coll Physicians Surg Pak 2023;33:325–34. 10.29271/jcpsp.2023.03.325 [DOI] [PubMed] [Google Scholar]
  • 23.Teixeira L de SL, Ceccato M das GB, Carvalho W da S, et al. Prevalence of smoking and associated factors in people living with HIV undergoing treatment. Rev Saude Publica 2020;54:108. 10.11606/s1518-8787.2020054001828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kacanek D, Jacobson DL, Spiegelman D, et al. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr 2010;53:266–72. 10.1097/QAI.0b013e3181b720e7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Do HM, Dunne MP, Kato M, et al. Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI). BMC Infect Dis 2013;13:154. 10.1186/1471-2334-13-154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev 2005;25:433–57. 10.1016/j.cpr.2005.02.001 [DOI] [PubMed] [Google Scholar]
  • 27.Ryan K, Forehand R, Solomon S, et al. Depressive symptoms as a link between barriers to care and sexual risk behavior of HIV-infected individuals living in non-urban areas. AIDS Care 2008;20:331–6. 10.1080/09540120701660338 [DOI] [PubMed] [Google Scholar]
  • 28.Antelman G, Kaaya S, Wei R, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr 2007;44:470–7. 10.1097/QAI.0b013e31802f1318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kingori C, Haile ZT, Ngatia P. Depression symptoms, social support and overall health among HIV-positive individuals in Kenya. Int J STD AIDS 2015;26:165–72. 10.1177/0956462414531933 [DOI] [PubMed] [Google Scholar]
  • 30.Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401. 10.1177/014662167700100306 [DOI] [Google Scholar]
  • 31.Moulis L, Le SM, Hai VV, et al. Gender, homelessness, hospitalization and methamphetamine use fuel depression among people who inject drugs: implications for innovative prevention and care strategies. Front Psychiatry 2023;14. 10.3389/fpsyt.2023.1233844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Briggs R, Carey D, O’Halloran AM, et al. Validation of the 8-item centre for epidemiological studies depression scale in a cohort of community-dwelling older people: data from The Irish Longitudinal Study on Ageing (TILDA). Eur Geriatr Med 2018;9:121–6. 10.1007/s41999-017-0016-0 [DOI] [PubMed] [Google Scholar]
  • 33.Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36. 10.1007/s11136-011-9903-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Zimet GD, Dahlem NW, Zimet SG, et al. The multidimensional scale of perceived social support. Journal of Personality Assessment 1988;52:30–41. 10.1207/s15327752jpa5201_2 [DOI] [Google Scholar]
  • 35.Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119–27. 10.1111/j.1360-0443.1991.tb01879.x [DOI] [PubMed] [Google Scholar]
  • 36.Bush K, Kivlahan DR, McDonell MB. The AUDIT Alcohol Consumption Questions (AUDIT-C) An Effective Brief Screening Test for Problem Drinking. Arch Intern Med 1998;158:1789. 10.1001/archinte.158.16.1789 [DOI] [PubMed] [Google Scholar]
  • 37.Bradley KA, DeBenedetti AF, Volk RJ, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007;31:1208–17. 10.1111/j.1530-0277.2007.00403.x [DOI] [PubMed] [Google Scholar]
  • 38.Barros AJD, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003;3:21. 10.1186/1471-2288-3-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Vittinghoff E, Glidden DV, Shiboski SC, et al. Regression methods in Biostatistics. In: Regression Methods in Biostatistics: Linear, Logistic, Survival and Repeated Measures Models. Boston, MA: Springer, 2012. 10.1007/978-1-4614-1353-0 [DOI] [Google Scholar]
  • 40.Van Minh H, Giang KB, Ngoc NB, et al. Prevalence of tobacco smoking in Vietnam: findings from the Global Adult Tobacco Survey 2015. Int J Public Health 2017;62(Suppl 1):121–9. 10.1007/s00038-017-0955-8 [DOI] [PubMed] [Google Scholar]
  • 41.World Health Organization . Mental Health in Vietnam. Factsheet, Available: https://www.who.int/vietnam/health-topics/mental-health [Google Scholar]
  • 42.Adams C, Zacharia S, Masters L, et al. Mental health problems in people living with HIV: changes in the last two decades: the London experience 1990-2014. AIDS Care 2016;28 Suppl 1:56–9. 10.1080/09540121.2016.1146211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gaynes BN, Pence BW, Eron JJ, et al. Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med 2008;70:505–11. 10.1097/PSY.0b013e31816aa0cc [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Arseniou S, Arvaniti A, Samakouri M. HIV infection and depression. Psychiatry Clin Neurosci 2014;68:96–109. 10.1111/pcn.12097 [DOI] [PubMed] [Google Scholar]
  • 45.Tran BX, Dang AK, Truong NT, et al. Depression and quality of life among patients living with HIV/AIDS in the era of universal treatment access in Vietnam. Int J Environ Res Public Health 2018;15:2888. 10.3390/ijerph15122888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Seid S, Abdu O, Mitiku M, et al. Prevalence of depression and associated factors among HIV/AIDS patients attending antiretroviral therapy clinic at Dessie referral hospital, South Wollo, Ethiopia. Int J Ment Health Syst 2020;14:55. 10.1186/s13033-020-00389-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hankebo M, Fikru C, Lemma L, et al. Depression and associated factors among people living with human immunodeficiency virus attending antiretroviral therapy in public health facilities, Hosanna Town, Southern Ethiopia. Depress Res Treat 2023;2023:7665247. 10.1155/2023/7665247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Prochaska JJ. Smoking and mental illness--breaking the link. N Engl J Med 2011;365:196–8. 10.1056/NEJMp1105248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull 2015;141:176–212. 10.1037/bul0000003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Fluharty M, Taylor AE, Grabski M, et al. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tob Res 2017;19:3–13. 10.1093/ntr/ntw140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Rubin LF, Haaga DAF, Pearson JL, et al. Depression as a moderator of the prospective relationship between mood and smoking. Health Psychol 2020;39:99–106. 10.1037/hea0000816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Taylor G, McNeill A, Girling A, et al. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014;348:g1151. 10.1136/bmj.g1151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kessler RC. Epidemiology of women and depression. J Affect Disord 2003;74:5–13. 10.1016/s0165-0327(02)00426-3 [DOI] [PubMed] [Google Scholar]
  • 54.Waldron EM, Burnett-Zeigler I, Wee V, et al. Mental health in women living with HIV: the unique and unmet needs. J Int Assoc Provid AIDS Care 2021;20:2325958220985665. 10.1177/2325958220985665 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Carmo Filho A do, Fakoury MK, Eyer-Silva W de A, et al. Factors associated with a diagnosis of major depression among HIV-infected elderly patients. Rev Soc Bras Med Trop 2013;46:352–4. 10.1590/0037-8682-1228-2013 [DOI] [PubMed] [Google Scholar]
  • 56.Chibanda D, Cowan F, Gibson L, et al. Prevalence and correlates of probable common mental disorders in a population with high prevalence of HIV in Zimbabwe. BMC Psychiatry 2016;16:55. 10.1186/s12888-016-0764-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Accortt EE, Freeman MP, Allen JJB. Women and major depressive disorder: clinical perspectives on causal pathways. J Womens Health (Larchmt) 2008;17:1583–90. 10.1089/jwh.2007.0592 [DOI] [PubMed] [Google Scholar]
  • 58.Noble RE. Depression in women. Metabolism 2005;54(5 Suppl 1):49–52. 10.1016/j.metabol.2005.01.014 [DOI] [PubMed] [Google Scholar]
  • 59.Bhatia MS, Munjal S. Prevalence of depression in people living with HIV/AIDS undergoing ART and factors associated with it. J Clin Diagn Res 2014;8:WC01–4. 10.7860/JCDR/2014/7725.4927 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Lichtenstein B, Laska MK, Clair JM. Chronic sorrow in the HIV-positive patient: issues of race, gender, and social support. AIDS Patient Care STDS 2002;16:27–38. 10.1089/108729102753429370 [DOI] [PubMed] [Google Scholar]
  • 61.Badru OA, Babalola OE. Significant others and not family or friend support mediate between stigma and discrimination among people living with HIV in Lagos State, Nigeria: a cross-sectional study. J Assoc Nurses AIDS Care 2023;34:96–104. 10.1097/JNC.0000000000000366 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Reviewer comments
Author's manuscript

Data Availability Statement

Data are available on reasonable request.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES